Sort
64,565 grants matching “drug discovery”
Mechanistic Characterization of Uterine Pain (M-CUP) to improve diagnosis and treatment for dysmenorrhea
$569,170Kevin Hellman · Endeavor Health Clinical Operations · R01 · FY2022 · HD
Cell biology of vasopressin-induced water channels
$569,145Dennis Brown · Massachusetts General Hospital · R01 · FY2013 · DK
KRAS G12C: Kinetic and Redox Characterization of Covalent Inhibition
$569,072Sharon L Campbell · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Engineering Multifunctional Nanoparticles
$569,049Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2009 · CA
Therapy for Metastatic breast cancer based on micro RNA silencing
$568,924Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2019 · CA
Analysis and prediction of molecular interactions
$568,923Sandor Vajda · Boston University (Charles River Campus) · R35 · FY2017 · GM
Host-mediated zinc sequestration during Acinetobacter baumannii infection
$568,915Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2022 · AI
Systems-level transcriptomic analyses to Identify mouse models of asthma
$568,910Samir Kelada · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
SYNTHESIS OF CARBOHYDRATE IMMUNOSTIMULANTS
$568,882Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
Developmental Funds
$568,857Jennifer A Pietenpol · Vanderbilt University · P30 · FY2014 · CA
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
$568,855Susan J Ramus · University Of Southern California · R01 · FY2014 · CA
Evolution of drug resistance in Candida glabrata
$568,821Gavin J Sherlock · Stanford University · R01 · FY2020 · AI
Genetics of Zebrafish Hair Cell Toxicity
$568,793David W Raible · University Of Washington · R01 · FY2017 · DC
Boston University Clinical and Translational Science Institute
$568,779Darrell N. Kotton · Boston University Medical Campus · TL1 · FY2017 · TR
MCSP TORFP NO. NIH-NINDS-20-02: MOURADIAN/DISNEY - BASE EC (PARKINSON'S)
$568,745Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2020 · DA
Graduate Training in Cellular and Molecular Pharmacology
$568,740Joan Heller Brown · University Of California, San Diego · T32 · FY2011 · GM
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
$568,737David R Sherman · Rbhs-New Jersey Medical School · U19 · FY2021 · AI
Defined microbial communities to prevent and eradicate infection by AMR pathogens
$568,690Robert A Britton · Baylor College Of Medicine · U19 · FY2023 · AI
Taking aim at HBV eradication using novel NRTIs and Capsid effectors
$568,676Stefan G Sarafianos · Emory University · R01 · FY2020 · AI
Harnessing the In Vitro Selection for Activity-based Proteomics and Chemical Probe Development
$568,671Casey John Krusemark · Purdue University · R35 · FY2024 · GM
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS
$568,555Cambria Biosciences, Llc · U01 · FY2005 · AI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases
$568,510Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2019 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases
$568,510Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2020 · AG
HT screens for the disruption of the T cell receptor CD3 interface
$568,500Luc Teyton · Scripps Research Institute, The · R01 · FY2011 · AI
Differential regulation of cardiomyocyte survival and hypertrophy
$568,420Peter Erhardt · Boston Biomedical Research Institute · R01 · FY2009 · HL